Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 6, 2006, Pages 395-398

  Schiff, Deborah E ^a   Roberts, William D ^a   Sue, Young Jin ^b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Dapsone; Methemoglobinemia; Methylene blue

Indexed keywords

AZITHROMYCIN; CIMETIDINE; COTRIMOXAZOLE; DAPSONE; METHEMOGLOBIN; METHYLENE BLUE; PREDNISONE; RITUXIMAB;

ANXIETY DISORDER; ARTICLE; CASE REPORT; CHRONIC DISEASE; COUGHING; CYANOSIS; DECREASED APPETITE; DYSPNEA; ECG ABNORMALITY; FATIGUE; FEVER; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; INFECTION PREVENTION; INJECTION PAIN; MALE; METHEMOGLOBINEMIA; NAUSEA; OXYGEN SATURATION; PARESTHESIA; PATIENT MONITORING; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PULSE OXIMETRY; SCHOOL CHILD; SYMPTOMATOLOGY; TACHYPNEA; THORAX PAIN; VOMITING;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CHILD; DAPSONE; HUMANS; MALE; METHEMOGLOBINEMIA; PNEUMONIA, PNEUMOCYSTIS; PREDNISONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 33745661486     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/00043426-200606000-00015     Document Type: Article

References (20)

1. Mandrell BN, McCormick JN. Dapsone-induced methemoglobinemia in pediatric oncology patients: case examples. J Pediatr Oncol Nurs. 2001;18:224-228.
2. Hughes WT. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review. Clin Infect Dis. 1998;27:191-204.
3. Lee KB, Nashed TB. Dapsone-induced sulfone syndrome. Ann Pharmacother. 2003;37:1044-1046.
4. Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001;45:420-434.
5. Stavola JJ, Noel GJ. Efficacy and safety of dapsone prophylaxis against Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1993;12:644-647.
6. Cruciani M, Concia E, Gatti G, et al. Dapsone prophylaxis against Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1994;13:80-81.
7. Barnett ED, Pelton SI, Mirochnick M, et al. Dapsone for prevention of Pneumocystis pneumonia in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1994;13:72-74.
8. Mirochnick M, Cooper E, McIntosh K, et al. Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children. Antimicrob Agents Chemother. 1999;43:2586-2591.
9. Williams S, MacDonald P, Hoyer JD, et al. Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome b5 reductase (Cb5R) enzyme levels. Pediatr Blood Cancer. 2005;44:55-62.
10. Lee BL, Medina I, Benowitz NL, et al. Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions. Ann Intern Med. 1989;110:606-611.
11. Plotkin JS, Buell JF, Njoku MJ, et al. Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review. Liver Transplant Surg. 1997;3:149-152.
12. Couper RT. Methaemoglobinaemia secondary to topical lignocaine/prilocaine in a circumcised neonate. J Paediatr Child Health. 2000;36:406-407.
13. Jaffe ER. Methaemoglobinaemia. Clin Haematol. 1981;10:99-122.
14. Ward KE, McCarthy MW. Dapsone-induced methemoglobinemia. Ann Pharmacother. 1998;32:549-553.
15. MacDonald RD, McGuigan MA. Acute dapsone intoxication: a pediatric case report. Pediatr Emerg Care. 1997;13:127-129.
16. Bradberry SM, Vale JA. Multiple-dose activated charcoal: a review of relevant clinical studies. J Toxicol Clin Toxicol. 1995;33:407-416.
17. Neuvonen PJ, Elonen E, Mattila MJ. Oral activated charcoal and dapsone elimination. Clin Pharmacol Ther. 1980;27:823-827.
18. Rhodes LE, Tingle MD, Park BK, et al. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. Br J Dermatol. 1995;132:257-262.
19. Coleman MD, Scott AK, Breckenridge AM, et al. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man. Br J Clin Pharmacol. 1990;30:761-767.
20. Rodriguez M, Fishman JA. Prevention of infection due to pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev. 2004;17:770-782, table of contents.